Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07127575 · ClinicalTrials.gov registry record · NA

Scalable Intervention for Stress Management

A NA study of Stress and Diaphragmatic Breathing, sponsored by Livotion.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT07127575 is a NA study of Stress and Diaphragmatic Breathing that is actively recruiting participants, run by Livotion. The registered enrollment target is 60 participants, below the 786-participant average among 152 other Stress trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07127575, a NA study of Stress and Diaphragmatic Breathing, is actively recruiting participants, sponsored by Livotion.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research is to measure the acceptance of a resistance breathing intervention and to assess whether it produces physiological and subjective effects in a laboratory setting.

Interventions

  • DEVICE Resistance Breathing Device
  • DEVICE Electronic Resistance Breathing Device

Study Locations (1)

Indiana

  • Purdue University - West Lafayette

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2025-08-01
Est. Completion 2025-09-30
Phase NA

Sponsor

Livotion

2 total trials

What the Registry Record Tells You About NCT07127575

The ClinicalTrials.gov registry entry for NCT07127575 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 152 other Stress trials with a reported enrollment target (92% lower). The listed sponsor is Livotion, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Stress appearing as the primary indexed condition, and to 2 interventions - of which Resistance Breathing Device is the first listed.

NCT07127575 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.

Frequently Asked Questions

What is clinical trial NCT07127575 about?

NCT07127575 is a clinical study titled "Scalable Intervention for Stress Management". The purpose of this research is to measure the acceptance of a resistance breathing intervention and to assess whether it produces physiological and subjective effects in a laboratory setting.

What is the current status of trial NCT07127575?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-08-01. Estimated completion is 2025-09-30.

What conditions does trial NCT07127575 study?

This clinical trial studies the following conditions: Stress, Diaphragmatic Breathing.

What interventions are being tested in trial NCT07127575?

The interventions under investigation include: Resistance Breathing Device (DEVICE), Electronic Resistance Breathing Device (DEVICE).

Who is sponsoring clinical trial NCT07127575?

This trial is sponsored by Livotion, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07127575 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stress

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.